Equity
€169,270 ▲ 18.6%
CARDIOPERF has made a profit without a break since 2018.
CARDIOPERF
Lifetime
13 annual accounts with figures on one time axispeak €51,995 (2019)
€26,785▲ 32.2%
lowest -€12,547 (2013)
€26,543▲ 68.9%
peak €169,270 (2025)
€169,270▲ 18.6%
€20,486▼ 1.4%
Board1 name since 2013
1 director
Documentsfilings and deeds
30-09-202661 days late
2025micro format
Gross margin from €20,256 to €26,785Result from €15,714 to €26,543Equity from €142,727 to €169,270Cash from €10,926 to €32,545
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 34,721 companies had the same profile as CARDIOPERF has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,721 companies, not a prediction for CARDIOPERF. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Deed on the registered office, the purpose, the legal form and the board
Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0521874648
Registered office moved from Beersel to Sint-Genesius-Rode
New registered office: Dreef Drève 23, in 1640 Sint-Genesius-Rode · Previous registered office: Groenejagersstraat 25, in 1653 Beersel · Gazette deed
Incorporation
published on 12-03-2013 · Gazette deed
Official details
Source: KBO- Status
- Active since 08-03-2013Normal situation
- Activity
- No activity registered in the KBO
- Establishment unit
- 2.218.874.604since 08-03-2013
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Insights on CARDIOPERF
CARDIOPERF files the micro format. That format states no turnover. The gross margin rose from -€4,800 in 2013 to €26,785 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about CARDIOPERF
- What is the company number of CARDIOPERF?
- The company number of CARDIOPERF is 0521.874.648. The VAT number is the same number with BE in front: BE 0521.874.648.
- Where is CARDIOPERF based?
- The registered office is at Kleetboslaan 20, 1650 Beersel.Company details
- What is the legal form of CARDIOPERF?
- CARDIOPERF is a private limited company (BV).
- When was CARDIOPERF founded?
- CARDIOPERF was founded on 08-03-2013.
- Is CARDIOPERF still active?
- Yes, CARDIOPERF is an active enterprise in the KBO register.
- What is the turnover of CARDIOPERF?
- The turnover in financial year 2025 is ≈ €110,000. This figure is estimated from the gross margin of €26,785 and 3,270 comparable companies of the same size. It probably lies between €63,000 and €190,000. It is a rough estimate.Financials
- Is CARDIOPERF profitable?
- In financial year 2025, CARDIOPERF made a profit of €26,543.
- Where can I find the annual accounts of CARDIOPERF?
- CARDIOPERF filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of CARDIOPERF due?
- CARDIOPERF must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.